Hansa Biopharma interim report January-March 2024
/PRNewswire/ -- Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and...
Source: prnewswire.com
Hitto Kaufmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hitto Kaufmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hitto Kaufmann Today - Breaking & Trending Today
Hansa Biopharma Year-end report January-December 2023
/PRNewswire/ -- Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and...
Source: prnewswire.com
Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma
/PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announced today that Dr....
Source: prnewswire.com
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q1 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen. And welcome to the Pieris Pharmaceuticals to host First Quarter 2023 Investor Call.
Source: insidermonkey.com
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q4 2022 Earnings Call Transcript
Operator: Hello and welcome to the Pieris Pharmaceuticals, Inc. Year-End 2022 Conference Call and Webcast. . A question-and-answer session will follow the formal presentation.
Source: insidermonkey.com